Bahrain begins error prevention drive:
This article was originally published in Clinica
Executive Summary
Bahrain is currently reviewing a draft law to establish an autonomous medical council which would eliminate medical errors and improve and enhance therapeutic and ethical standards in the country's public and private medical institutions and pharmacies. The duties of the new body will include: regulating the yearly renewal of licences for private clinics and pharmacies; setting standards for new institutions; setting quality standards for medical centres; monitoring performance-cost ratios; evaluation of performance; taking action against standards or costs violations; and taking action on patient complaints and suggestions.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.